A Study of the Safety, Tolerability, and Pharmacokinetics of AGG-523 in Healthy Japanese Males
NCT00434785
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
AGG-523
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer